Athletics Anonymous // Blog // Performance & Longevity Est. 2024
← Back to Blog
// Opinion · June 2026

Peptides Are Having Their Bitcoin Moment.
Most People Pushing Them Have No Idea What They're Talking About.

By Jordan Richey  ·  Athletics Anonymous  ·  8 min read

Your coworker has a protocol. Your gym buddy is cycling BPC-157 and TB-500 he ordered from a "research chemical" site. The guy at the supplement counter just explained IGF-1 half-lives to you with total confidence. This is what a gold rush looks like before anyone knows there's gold.

I've Seen This Before

Bitcoin in 2009 was real. The underlying technology was real. The potential was real. What was also real: an enormous number of people who had no idea what they were talking about, selling certainty to people who had no way to verify it.

That's exactly where peptides are right now.

The compounds themselves have legitimate research behind them. BPC-157 has shown accelerated tendon and gut healing in animal models. TB-500 (Thymosin Beta-4) plays a genuine role in cell migration and tissue repair. Semaglutide and tirzepatide have transformed how medicine approaches obesity. GLP-1 agonists are not a fad. The research is there.

But what you're seeing on social media, in gym locker rooms, and in wellness subreddits is not the research. It's a game of telephone that started with a PubMed abstract and ended with a guy selling you a $200 peptide kit with a PDF "dosing guide" he wrote himself.

The problem with Bitcoin in 2009 wasn't Bitcoin. The problem was everyone who showed up to sell you Bitcoin.

Why Everyone Sounds Like a Doctor

Peptides have a language barrier built in. The names alone sound clinical. BPC-157. Ipamorelin. CJC-1295. Semax. The fact that you're pronouncing them correctly makes you feel like you know something. The fact that you can recite half-lives and injection sites makes you sound like you do.

This is exactly how crypto worked. People learned to say "blockchain" and "decentralized ledger" with total confidence in 2017. They were not wrong that those words referred to something real. They were wrong that understanding the vocabulary meant they understood the system.

Peptide grifters figured this out fast. If you give someone enough terminology to feel educated, they stop asking questions. They start asking for protocols instead.

So you end up with a landscape where the loudest voices are coaches with no clinical background, "biohackers" with podcasts and no accountability, and supplement companies funding their own research. The guys who actually know what they're talking about -- the MDs, the PhDs, the researchers who spent 20 years in a lab -- are buried under the noise.

The Specific Problem with Research Chemical Sites

Most peptides are not FDA-approved for human use. The ones people are self-administering -- BPC-157, TB-500, Selank, Epithalon -- exist in a legal gray zone sold as "for research purposes only." This means no quality control standards. No third-party testing requirements. No accountability when the product is underdosed, mislabeled, or contaminated.

The Bitcoin parallel holds here too. In 2013, people were sending money to exchanges with no regulatory oversight, no insurance, no recourse. Some of those exchanges collapsed. Some stole the funds outright. The technology was fine. The infrastructure around it was not.

The peptide compounds may be legitimate. What you're injecting from an unverified source may not be.

This Doesn't Mean Peptides Are Nonsense

Bitcoin is worth something now. The technology did what the serious researchers said it would do. Peptide therapy is headed somewhere real too. The clinical applications being studied -- wound healing, cognitive function, metabolic health, GH secretagogues -- are not pseudoscience.

The difference between Bitcoin then and now is infrastructure. Regulated exchanges. Custody solutions. Institutional involvement. The early adopters who survived made serious money. The ones who trusted the wrong people lost everything.

Peptide therapy needs the same maturation. Right now we're still in the phase where most of the infrastructure is unregulated, most of the "experts" are self-appointed, and most of the protocols circulating online are not based on clinical evidence.

That will change. It's already changing. But we're not there yet. And acting like we are is how people get hurt.

What You Should Actually Do

If you're curious about peptide therapy, you have two options. Talk to a physician who specializes in this area and has the lab infrastructure to monitor your bloodwork before, during, and after. Or spend time with the people who have spent their careers at the intersection of research and application, who have the credentials to back their claims, and who are not selling you a product.

Those people exist. They're not the loudest voices in the room. Here's where to find them.

Where to Actually Learn

These four people represent the clearest signal in a very noisy space. None of them have a peptide kit to sell you. All of them cite their sources.

Andrew Huberman
// Huberman Lab
Stanford neuroscientist and tenured professor. His podcast covers the science behind sleep, hormones, performance, and recovery with a level of rigor that most health media doesn't come close to. He has covered peptides, GLP-1 agonists, and growth hormone secretagogues directly.
hubermanlab.com →
Peter Attia
// The Drive Podcast
MD with a background in surgical oncology and a practice focused entirely on longevity medicine. Author of Outlive. His work on metabolic health, rapamycin, GLP-1s, and hormone optimization is the most clinically grounded content available to a general audience.
peterattiamd.com →
Rhonda Patrick
// FoundMyFitness
PhD in biomedical science. Her research focus is micronutrients, genetics, and aging. She reads the primary literature and explains it accurately. When she covers something she is uncertain about, she says so. That alone puts her in a different category from most health communicators.
foundmyfitness.com →
Andy Galpin
// RAPID Health Optimization
PhD in human bioenergetics. Has spent his career studying how the human body adapts to training at a cellular level. His frameworks for understanding performance, recovery, and adaptation are some of the most practically applicable in the field. No gimmicks.
andygalpin.com →

The signal is out there. The problem is you have to want it more than you want the shortcut. Most people don't. That's why the grifters keep winning.

Spend time with the four people above. Read the actual studies they cite. Talk to a real physician before you inject anything. And be honest with yourself about whether the guy in your DMs with a peptide protocol has the credentials to back what he's selling you.

Bitcoin made a lot of people rich. It also wiped out a lot of people who trusted the wrong infrastructure. The underlying asset matters less than what you do with the information around it.

// Athletics Anonymous

Your bloodwork is the actual signal.

Before any peptide protocol, optimization stack, or hormone intervention, you need to know your baseline. Testosterone, cortisol, insulin, free T3. That data tells you what your body actually needs. Everything else is noise.

Apply for Coaching →